Neurology
Commentary
DTC genetic health risk tests: Beware
The Food and Drug Administration recently authorized 23andMe to provide consumers with results of germline DNA sequence variants associated with...
Feature
Spotlight shifts to active treatment for concussions
Concussion management is on the cusp of dramatic change.
News from the FDA/CDC
FDA approves Emflaza for Duchenne muscular dystrophy
Emflaza (deflazacort) becomes the first corticosteroid to be approved by the Food and Drug Administration for Duchenne muscular dystrophy.
Conference Coverage
Toddlers’ neurodevelopmental deficits linked with maternal diabetes
Children born to obese mothers with insulin-requiring type 2 diabetes showed neurodevelopmental deficits at age 2 years.
Conference Coverage
Children with infantile spasms or nonsyndromic epilepsy achieve similar outcomes
HOUSTON – Infants and children who had epilepsy that was not identified as being part of a syndrome fared slightly worse in developmental outcomes...
Conference Coverage
Chest-worn seizure detection device shows promise
An investigative, chest-worn device shows promise for detecting a wide range of seizure types in children with epilepsy, results from a small...
News from the FDA/CDC
First drug for spinal muscular atrophy approved
The antisense oligonucleotide drug nusinersen is the first therapy approved by the U.S. Food and Drug Administration to treat children and adults...
Conference Coverage
Psychiatric comorbidities common in newly diagnosed pediatric epilepsy cases
HOUSTON – About one in three children diagnosed with new-onset epilepsy present with psychiatric diagnoses at the onset, results from a single-...
Conference Coverage
Study eyes fracture risk in pediatric patients taking antiepileptic drugs
HOUSTON – The incidence of fractures in pediatric patients taking antiepileptic medication stands at an estimated 1.1%.
Conference Coverage
Infantile spasms diagnosis, treatment too often delayed
HOUSTON
Commentary
Transition to adult epilepsy care done right
When patients are too old to be seen by pediatric specialists, the process of being transferred – instead of transitioned – to new providers does...